Top Story

Percutaneous VAD for right heart support receives FDA approval

January 28, 2015

The FDA has approved under a Humanitarian Device Exemption the first single-access percutaneous ventricular assist device for right heart support, according to a press release issued by Abiomed.

The percutaneous VAD (Impella RP System) is indicated for providing circulatory assistance for up to 14 days in pediatric or adult patients with acute right HF or decompensation following left VAD implantation, MI, heart transplant or open-heart surgery, according to the release.

In the Journals

Solid organ transplantation saved more than 2 million life-years since 1987

January 28, 2015
In a new retrospective analysis, solid organ transplantation saved more than 2 million life-years, including more than 400,000 among liver transplant recipients, during…
FDA approvals

FDA approves ablation catheter with flexible tip to treat cardiac arrhythmias

January 28, 2015
St. Jude Medical announced that the FDA has approved an ablation catheter with a flexible tip for treatment of patients with cardiac arrhythmias.The ablation catheter…
Ariel Roguin

Top 10 interventional cardiology stories in 2014

January 27, 2015
The past year has been one of major developments in the field of interventional cardiology, with hot topics including FDA device approvals and key outcomes from various…
In the Journals

Leisure-time physical activity reduced CV risk in CAD patients with and without diabetes

January 27, 2015
In patients with coronary artery disease, whether they had type 2 diabetes or not, routine leisure-time physical activity was inversely associated with short-term…
More News Headlines »
CME
Individualizing T2DM Treatment: Determining Optimal Pathways That Lead to Achieving Target Goals

Individualizing T2DM Treatment: Determining Optimal Pathways That Lead to Achieving Target Goals

This activity is supported by educational grants from Lilly USA, LLC and Novo Nordisk.

The prevalence of type 2 diabetes mellitus has escalated in recent years and targeting treatmentcontinues to be a…
More »
Meeting News Coverage Video
thumbnail for video 3945938325001

Kirk N. Garratt, MD: Prolonged DAPT beneficial in patients with paclitaxel-eluting stents

December 16, 2014
CHICAGO — In this video, Kirk N. Garratt, MD, of the Lennox Hill Hospital, New York, outlines results of a study…
More »
CME
Obesity Consults: Volume 2, Number 1

Obesity Consults: Volume 2, Number 1

This activity is supported by an educational grant from Vivus, Inc.

Obesity is suboptimally managed in clinical practice despite the availability of relevantguidelines and evidence-based…
More »
morganatic-roan
morganatic-roan